For US residents only.

Understanding Treatment

KISQALI® (ribociclib) + HORMONE THERAPY OR FULVESTRANT

KISQALI Works in Combination with a Hormone Therapy or Fulvestrant

KISQALI® (ribociclib) is a targeted treatment, meaning it blocks, or interferes with, substances that play a role in cancer cell growth. Targeted therapies affect cancer cells, but can also affect healthy cells. To understand how KISQALI works with hormone therapy (eg, letrozole or anastrozole) or fulvestrant, it’s important to also understand the role that hormones/hormone receptors play in causing your type of cancer cells to grow and divide.

 

KISQALI works in combination with a hormone therapy or fulvestrant to help delay disease progression.

Click here to learn more about results with KISQALI.